Zoono Group Limited (ASX:ZNO)

Australia flag Australia · Delayed Price · Currency is AUD
0.0320
-0.0010 (-3.03%)
Aug 1, 2025, 4:10 PM AEST
-3.03%
Market Cap11.37M
Revenue (ttm)1.01M
Net Income (ttm)-4.06M
Shares Out355.43M
EPS (ttm)-0.01
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume14,423
Average Volume94,861
Open0.0330
Previous Close0.0330
Day's Range0.0320 - 0.0330
52-Week Range0.0220 - 0.0770
Beta1.10
RSI52.64
Earnings DateAug 20, 2025

About Accolade

Zoono Group Limited, together with its subsidiaries, engages in the research, development, and sale of a range of antimicrobial products in New Zealand, Australasia, Asia, the United States, India, the United Kingdom, and Europe. Its products include hand and surface sanitisers, textile applicator, and mould remediation products. The company serves facilities management, transportation, education, hospitality, and healthcare sectors. Zoono Group Limited was founded in 2007 and is headquartered in Auckland, New Zealand. [Read more]

Founded 2007
Employees 1
Stock Exchange Australian Securities Exchange
Ticker Symbol ZNO
Full Company Profile

Financial Performance

In 2024, Zoono Group's revenue was 1.05 million, a decrease of -68.55% compared to the previous year's 3.34 million. Losses were -9.09 million, 2493.7% more than in 2023.

Financial Statements

News

There is no news available yet.